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Abstract
The aim of this consensus statement was to discuss transition of patients with ADHD from child to adult healthcare
services, and formulate recommendations to facilitate successful transition. An expert workshop was convened in June
2012 by the UK Adult ADHD Network (UKAAN), attended by a multidisciplinary team of mental health professionals, allied
professionals and patients. It was concluded that transitions must be planned through joint meetings involving referring/
receiving services, patients and their families. Negotiation may be required to balance parental desire for continued
involvement in their child’s care, and the child’s growing autonomy. Clear transition protocols can maintain standards of
care, detailing relevant timeframes, responsibilities of agencies and preparing contingencies. Transition should be viewed
as a process not an event, and should normally occur by the age of 18, however flexibility is required to accommodate
individual needs. Transition is often poorly experienced, and adherence to clear recommendations is necessary to ensure
effective transition and prevent drop-out from services.
Background
Transition can be defined as ‘the process of change from
one stage (state) to another stage (state)’. There are many
transitions that an individual makes throughout life, be
they through psychosocial stages of development [7] or
stages of cognitive development [22], and perhaps the
most important transition is from adolescence to adult-
hood. This is a period of immense significance both in
social and psychological terms, as well as in legal terms
(i.e. legally becoming an adult at age 18). This is a period
where young people are likely to move away from home,
either to go to college/university or for job opportun-
ities, start new relationships and assume new roles and
responsibilities. This is also a period when many experi-
ment in life, including alcohol and illicit substances. Any
disruption during this period is likely to have longer last-
ing adverse effects on the young person’s development,
realisation of their potential and possibly affect their
psychological wellbeing.
Young people with mental health conditions are par-
ticularly vulnerable during the transition period, and
disruption of care during transition adversely affects the
health, wellbeing and potential of this vulnerable group
[15, 25]. Poor transition leads to disruption in continuity
of care, disengagement from services and is likely to lead
to poor clinical outcomes [25]. Ideally, transition should
be a planned, orderly and purposeful process, taking into
account developmental and illness specific needs [24].
For the majority of patients transition is poorly planned,
poorly executed and poorly experienced [25, 26].
ADHD and transition
Attention deficit hyperactivity disorder (ADHD) is esti-
mated to affect up to five per cent of school-age children
and adolescents in the UK [20], with a peak incidence in
those aged between six and 12 years [18]. Although
ADHD was previously thought of as a childhood condi-
tion, meta-analysis of follow-up studies found that 15 %
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of children with ADHD continued to have clinical fea-
tures that met formal diagnostic criteria at the age of
25 years, and a further 50 % continued to suffer signifi-
cant impairment into adulthood [8, 31]. In addition, co-
morbid problems such as mood and anxiety disorders
and substance misuse persist or develop in adulthood.
Other associated problems that may beset adults include
difficulties in interpersonal relationships, problems with
further education, poor employment opportunities, a
propensity for dangerous risk-taking behaviours, and
high rates of offending [1, 32]. For a review of ADHD in
adolescence, see [30]. This constellation of clinical prob-
lems and functional impairments emphasises the clear
need for mental health services for adolescents and adults
with ADHD. Yet data ascertained from 1,636 patients in
the UK General Practitioner Research Database, contain-
ing data of over three million active patients between the
eight year period 1999–2006, reported a great reduction
in prescribing patterns during adolescence, in fact hardly
any patients were receiving ADHD medication by age 21
[17]. Given the findings of Faraone et al. [8] and Cheung
et al. [5], this drop in service utilisation cannot possibly re-
flect spontaneous remission of ADHD symptoms. Of
greater concern is that it occurs at a time when young
people need the support of these services the most, as
adolescence is a risk period when mental health problems
may become more complex and serious disorders emerge.
NICE guidelines
In 2008, the National Institute for Clinical Health and
Excellence (NICE) produced guidance about the recog-
nition and management of ADHD across the life span.
They emphasised that ADHD was a life-long condition
and provided clear recommendations that care should
continue from childhood to adulthood if symptoms per-
sist. They also provided, for the first time in the UK,
clear guidance for the development of transition ar-
rangements from child to adult services:
1. Young people with ADHD who are receiving
healthcare from child and adolescent mental health
services (CAMHS) or paediatric services should
normally be transferred to adult mental health
services (AMHS) if they continue to have significant
symptoms of ADHD or other coexisting conditions
that require treatment.
2. Transition should be planned in advance by both the
referring service and the receiving service. If needs
are severe and/or complex, use of the Care
Programme Approach (CPA) should be considered.
3. Patients should be reassessed at school-leaving age to
establish the need for continuing treatment into adult-
hood. If treatment is necessary, arrangements should
be made for a smooth transition to adult services,
with details of the anticipated treatment and services
that the young person will require made clear.
4. Precise timing of the transition arrangements may
vary locally, but the transfer should usually be
completed by the time the patient is 18 years of age.
5. During the transition to adult services, a formal
meeting involving CAMHS and/or the paediatric
service and AMHS should be considered, and full
information about the adult service should be
provided to the patient.
6. For young people aged 16 years and older, the CPA
should be used as an aid to transfer between
services. The young person, and when appropriate
the parent/carer, should be involved in the planning.
7. After transition, a comprehensive patient assessment
should be carried out. The assessment should look
at personal, educational, occupational and social
functioning, and it should evaluate any coexisting
conditions, notably drug misuse, personality
disorders, emotional problems and learning
difficulties.
8. Trusts should ensure that specialist ADHD teams
for children, young people and adults jointly develop
age-appropriate training programmes for the diagno-
sis and management of ADHD.
Common practice in the UK
Although publication of the NICE guidelines has raised
awareness of the need for appropriate arrangements for
the transfer of young people with ADHD from child to
adult healthcare services, AMHS in the UK for ADHD
remain patchy. Furthermore, there is significant variation
in the ways that services are organized across the UK
and it is likely that some of this variation impacts signifi-
cantly on the effectiveness of transition between adoles-
cent and adult services. Healthcare for children with
ADHD is generally provided by either community paedi-
atric services or by CAMHS, or sometimes a combin-
ation of the two, that may or may not work in a joined-
up manner. The interface between these services and
AMHS is often complex with the potential for significant
gaps. A survey conducted by Hall et al. [13] reported the
absence of joint working between CAMHS and AMHS
to be 66 % and 59 % of child and adult services, respect-
ively. Furthermore, all 24 respondents from adult ser-
vices reported having no official transition policy in
place, and 89 % of National Health Service (NHS) Men-
tal Health Trusts reported an absence of dedicated staff
to support the transition. Surveys of NHS Trusts have
also indicated a nationwide lack of accurate data pertain-
ing to both the number of adults with ADHD within in-
dividual trusts, and the number of children/adolescents
transitioning to adult services [12].
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There seems to be a difference in practice between
community paediatric and child & adolescent mental
health services. Traditionally, paediatric services have
stopped providing care for medical problems early in
adolescence, although most now continue to provide
care until school-leaving age. In the past most CAMHS
generally stopped providing care either at 16 years of
age or at school-leaving age (whichever was later). How-
ever, there is now a shift towards CAMHS continuing to
provide care for patients up to 18 years of age regardless
of school status. It has been suggested that AMHS are
often too rigid in their age criteria for transition, with re-
ports of refusals to consider transition until the individual
reaches the age of 18 [3]. To further complicate issues it is
reported anecdotally that whatever the technical cut-off
age may be, many paediatric and CAMHS teams continue
to see young people well past this age, due to the difficul-
ties in transferring care to adult services [33]. Hence there
is a mismatch in the expectation about when care should
be passed from adolescent to adult services. Such incon-
sistencies have been reported to be disruptive and unset-
tling for patients [28] and this disruption to continuing
care is detrimental to overall clinical care from both an in-
dividual and service perspective.
Expert workshop
In order to facilitate further discussion about the transi-
tion from child to adult services and develop more expli-
cit and comprehensive recommendations for clinicians,
commissioners and policy makers, an expert workshop
– “ADHD: Transition from Adolescence to Adult” – was
convened in June 2012 in London by the UK Adult
ADHD Network (UKAAN) [29]. UKAAN is an organisa-
tion founded in 2009 by a group of mental health spe-
cialists in response both to the NICE guidelines [19] and
to recommendations from the British Association for
Psychopharmacology (BAP) [21] that aims to provide
support, education, research and training for mental
health professionals working with adults with ADHD.
The workshop was attended by experts in the field of
ADHD, working across services, together with allied
professionals and patients. The workshop consisted of a
series of presentations summarising the transition
process from the perspective of these experts. The work-
shop first considered the findings of the TRACK study
[27] which sought to identify factors that facilitate or im-
pede effective transition more generally within the
healthcare system. The National Institute for Health and
Care Excellence,[19]) guidelines for transitioning young
people with ADHD and the extension to these recom-
mendations proposed by Young et al. [33] were
reviewed, and consideration was given to the broader
clinical, educational, occupational, and social needs of
young people in this age group. There followed an in
depth discussion tabling a consensus for detailed recom-
mendations on the provision of transition services for
patients with ADHD.
Setting the Context – Findings from the TRACK Study
The expert workshop commenced with a summary of the
findings from the Transitions of Care from CAMHS to
AMHS (TRACK) study [27]. The specific aims of the
TRACK study were to identify factors that impede or facili-
tate effective transitions and continuity of care across the
mental health services for children and adolescents, cover-
ing all disorders and not limited to ADHD, and to make
recommendations about the configuration of services.
Healthcare transitions are commonly defined in the
literature as a purposeful, planned process that addresses
the medical, psychosocial and educational or vocational
needs of young people and young adults with chronic
physical and medical conditions as they move from child
centred to adult orientated healthcare systems. An im-
portant context for considering healthcare transition for
young people with long-term health conditions is that
they typically face several types of transition simultan-
eously – developmental transitions from childhood to
adolescence to adulthood, situational transitions from
child services to adult services, and possibly even transi-
tions from relative health to illness or, indeed, some-
times in the other direction. As young people make
these transitions they generally take on more responsi-
bility from their parents/carers for all aspects of their
healthcare, as well as for other areas of their life. As a
consequence it is inevitable that, at the same time, par-
ents/carers face a transition process of their own. Hence
the transition from child to adult health services brings
service-related challenges associated with an inherent
shift from a family-orientated service to an individual-
orientated service. Whilst the TRACK study focused on
those transitioning between child and adult services, not
all patients with ADHD will necessarily be in contact
with child services at the time of transition. Indeed many
of those with ADHD will not have received specific
healthcare for their problems during childhood and ado-
lescence – and may be presenting formally for the first
time at transition from adolescence to adulthood.
The TRACK project was a multi-site mixed models
study, undertaken in six mental health trusts within
England. The key findings were:
 Whilst many of the identified transition protocols
were based on policy documents, there was
evidence of a policy-practice gap, as services dif-
fered considerably on their interpretation of both
policy and the recommendations for the practical
aspects of transition. Although most of the proto-
cols identified the patient as central to the
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transition process, few, if any, specified ways of
preparing them for it.
 Optimal transitions were defined as those
demonstrating evidence of: information transfer
across services; a period of joint working between
CAMHS and AMHS; transition planning involving
key professionals from both services, patients and/or
their parent/carers; and continuity of care.
Transitions were considered sub-optimal if they
failed to meet one or more of these criteria. The
main findings were that, whilst around 80 % of pa-
tients were considered suitable for transition, around
one-third were not referred to adult services. Adult
services accepted the vast majority of referrals, how-
ever of those accepted around 20 % were discharged
without being seen and only four per cent experi-
enced optimal transition.
 An organisational analysis showed that CAMHS
were seen as being more person-centred, holistic
and family orientated, and adult services as more
medication focused and crisis orientated. Facilitators
for transition included: dedicated transition posts,
joint working, early communication and greater in-
volvement of carers. Barriers for transition included
variability of eligibility criteria, differing thresholds
between AMHS and CAMHS, communication prob-
lems between services and lack of confidence
amongst adult staff on managing young people in
general, and specifically relating to those with neuro-
developmental disorders.
 In a qualitative study of patients’, carers’ and mental
health professionals’ experiences of transitions,
participants described the importance of transfer
planning meetings, joint working between the two
services, and good information transfer. Interestingly
most young people preferred not having their
parents/carers involved with their care at AMHS, and
many said that they appreciated the break from this
family orientated system because they wanted to be
more autonomous. On the other hand parents/carers
wanted greater involvement with adult services.
Despite making up a large proportion of the case-
loads of CAMHS services, children with ADHD were
relatively under-represented within the TRACK sam-
ple, making up just under 10 % of the total sample.
Only six out of the 15 cases reviewed were transi-
tioned to AMHS and none of these were classified as
being ‘optimally transitioned’. Overall those young
people with neurodevelopmental disorders such as
ADHD and autism spectrum disorders, and those
with emotional disorders or emerging personality dis-
orders, were more likely to fall through the gaps.
Those with serious mental illness, such as psychosis,
patients who are receiving pharmacological treatment
and with history of inpatient treatment are more
likely to be accepted for transition.
Patients’ perspectives
There followed representations from patients on their
experience and knowledge of the transition process. The
transition period is a time of changing responsibilities,
in which the young person is assuming greater auton-
omy and increased responsibility for his or her own care.
Nevertheless, it is important that parents/carers should
feel that they are involved in the transition process. This
can be challenging because young people do not always
want their parents/carers to continue to be involved in
their medical care or the management of their condition.
However, AMHS need to be willing to work more
closely with parents/carers and to recognise that on-
going parental support for the young person is often ne-
cessary. This of course can only be achieved with the
patient’s permission.
It was stressed that transition should start much earl-
ier than is generally recognised. There was a clear call
for psychoeducational material for patients and families,
as they described wanting to be informed much earlier
in the process about their condition and what to expect
as they move into adulthood. Specifically they asked for
greater detail about their diagnosis and its prognosis,
treatment options, involvement in decision making and
a specified care plan. In addition, they wanted the op-
portunity to share with professionals their feelings and
their desire to take control of managing their condition
and play an active role in their care plan.
It was emphasised that transition needs to be seen as a
“process” rather than an “event”. Specifically, young
people need to know what can be expected of these ser-
vices, what AMHS offer and what they do not offer.
They thought that transition meetings attended by
CAMHS and AMHS were a good idea as this would fa-
cilitate a smoother transition. The potential value of life-
span clinics in the management of ADHD was
highlighted. Patients were mindful however of the sup-
port they need in this process due to organisation and
planning deficits. Support groups play an important role
in the process, providing support for the young person
and their family; the latter for the first time have to take
a step back with a less proactive role.
The experience described at the workshop strongly
resonates with perspectives reported in the Transition
Into Adult Mental Health Services (TRAMS) study [28].
This was a qualitative study of the experiences of 10
young people with ADHD, and their parents/carers, in
transition from CAMHS to AMHS. Four key themes
were identified from the analysis:
Young et al. BMC Psychiatry  (2016) 16:301 Page 4 of 10
1. Clinician Qualities and Relationship: These were
identified to be an integral component of patient
satisfaction, with a particular focus on the need for
continuity of listening throughout the transition
process, non-judgemental support and a practical,
solution-focused approach targeting achievable and
realistic goals.
2. Responsibility of Care: A number of issues arose
regarding the question of who is responsible for
providing care and ensuring continuity of care. From
the young person’s perspective, a conflict can
emerge between the greater autonomy expected in
AMHS and the difficulties they experience in areas
such as planning and organisation, for which they
typically rely on parent/carer support. Inevitably for
parents/carers, there is a responsibility to balance
support and autonomy. Ultimate responsibility for
providing a consistent transition lay with clinicians,
with the importance of joint meetings between
CAMHS and AMHS, alongside patients and their
families, as well as an overall clear plan for handover
suggested as integral components of a seamless
transition.
3. Nature and Severity of Problems: Acceptance by
AMHS appeared to be contingent on the nature and
severity of the young person’s problems. There was a
suggestion that transition may go more smoothly for
those presenting with more severe problems, such as
self-harming behaviours, and higher levels of comor-
bidity. For those whose problems were well con-
trolled at the time of transition, neither the AMHS
nor the young person themselves recognised the
need for the on-going support required to sustain
this level of health.
4. Expectations of AMHS: The expectations of AMHS
from patients and their families were often high,
although many of these are unlikely to be met (i.e.
assistance with housing). It is essential therefore that
CAMHS clinicians do not provide unrealistic
expectations of AMHS, with clear information
offered prior to transition concerning exactly what
can and cannot be offered.
The transition process
Most AMHS are set up to provide care for patients with
serious mental disorders such as psychosis. In the
TRACK study, only one in five of the 17 year olds in
CAMHS with neurodevelopmental disorders (including
ADHD) made a successful transition to adult services
[27]. This contrasts with the more successful transition
of young people with psychosis and other conditions
considered to be serious mental disorders. Moreover, ex-
perience suggested that patients with ADHD and comor-
bid mental health problems, such as depression and
suicidal ideation, often have an easier transition to adult
services than patients diagnosed with ADHD alone.
Nevertheless, one-half of all patients fail to adhere to
treatment guidelines [9] and discontinue treatment
within 2–3 years of starting pharmacological therapy
[11, 34]. Some common reasons for the discontinuation
of treatment are: adverse effects, ineffectiveness/subopti-
mal response, poor adherence, patient/caregiver decision
and symptom relief. Other less common, although im-
portant, reasons include a dislike of medication, dosing
inconvenience and social stigma [10].
It needs to be emphasised that transition to adult care
is a process, rather than an event. For their part,
CAMHS should provide timely and accurate information
to patients about adult services and develop specific
mechanisms to overlap the transitional arrangements
with adult services. The transition process can be used
to prompt a review of what other organisations may be
required in the patient’s care. Indeed, this is an oppor-
tunity to inform appropriate agencies and organisations,
with the patient’s consent, of their current circum-
stances. For this to be achieved, a good working know-
ledge of the common partner organisations in the area is
crucial. These may be statutory and/or local organisa-
tions, such as child protection services, the local author-
ity (for assessment for social care), local educational
facilities and resources, court diversion services, and
youth offending teams. In addition, there are an increas-
ing number of voluntary and third-sector agencies that
provide help and support. It is also advisable to involve
the patient’s general practitioner (GP) because often this
is the most stable service provider during the period of
transition.
It was proposed that for the transition to adult care to
work well, adult psychiatry needs to accept referrals
from CAMHS and community paediatric services, and
develop a better understanding of their needs. This will
involve targeted continuing professional education on
ADHD and, in particular, on the transition process. Of
concern is that there is no specific provision to ensure
ongoing care for ADHD patients who are not accepted
by AMHS. There followed discussions regarding the best
model for service provision and, in particular, whether
adult-focused neurodevelopmental services need to be
specifically developed. These already exist in some parts
of the UK and were considered useful (see Table 1). To
avoid excessive resource implications and an unneces-
sary division to the process, these are best located as an
extension of CAMHS with a set agenda that includes
psychoeducation, goal setting, risk reduction, coping
strategies, employment and education. Additional con-
sultations can be added on an ‘as needed’ basis, e.g. with
a pharmacist, social worker, psychiatrist, psychologist
and/or a member of the youth offending team.
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ADHD, education and employment
We can be fairly confident that key transitions, and in
particular, those bridging secondary education and the
world of further learning, independent living and work,
constitute a period of heightened vulnerability in the life
of any young person with ADHD.
However, the absence of a reliable evidence-base to in-
form generalisations about the employment experience
of young people transitioning from school or college to
the world of work is complicated by the heterogeneity of
the ADHD population in terms of cognitive ability, co-
morbidity, gender expression, and treatment uptake, as
well as geographical variations in the labour market.
Whilst it is fair to suggest that young people with
ADHD suit better those occupations that provide nov-
elty, physical activity and immediate feedback, and
which are thus non-repetitive, highly structured and
lacking in organisational/time-management demands,
the prospects for any individual are likely to hinge on a
number of other factors which may be either directly or
indirectly related to the way that ADHD has manifested
itself during their formative years.
Sufficient anecdotal evidence exists to complement
studies in USA and Europe to suggest that rates of
economic activity and thus income levels are signifi-
cantly lower for young adults with ADHD, and that
such differentials often persist throughout the life
span [4, 6, 16]. The treatment effect is poor for occu-
pational outcomes [2], however there is an emerging
body of data to support the positive impact of
personalised assistance in negotiating the labour mar-
ket by helping job-seekers with the application and
interview process, providing structures in daily living
to manage financial obligations and punctuality, and
in averting negative tendencies towards substance
misuse, social conflict and offending [14, 23]. Like-
wise, adjustments in the workplace, such as a re-
framing of organisation demands or support with
time-management, may allow workers with deficits in
these areas to exploit relative strengths in others and
thus provide a net gain to the employer [1]. Programmes
to improve the employability of people with ADHD are
likely to be most effective when they are sensitive to the
current needs and future potential of each individual,
multi-modal in delivery, and which address gaps in prior
learning that impair recruitment prospects.
Consensus
Having considered all the available evidence and ex-
pert opinion, the expert group deliberated the recom-
mendations that need to be made to achieve a
smooth and effective transition from child to adult
Table 1 Transition practice in Leicestershire
Leicestershire have developed a robust transition protocol ensuring that
all referrals from children’s services are carefully reviewed and
appropriate action is taken. In Leicestershire, referral acceptance by the
adult ADHD service is 100 %. Children services are advised to start the
referral well in advance of the point of transition on the patient’s 18th
birthday. They are also advised not to discharge the patient before they
have been seen by the adult service. This ensures that the patient is
never lost between the two services. In case the patient does not
attend the appointment arranged by the adult ADHD clinic, the
referring clinician is contacted for further advice and efforts are made to
encourage the patient to attend. When dealing with complex cases or
difficult to engage patients, a period of joint working has also been
found to be useful.
Recognising the vulnerability of patients through this period of
transition and the need to ensure continuity of care and stability, a
great degree of flexibility is exercised when dealing with this group of
patients. Even when the patient is not keen on taking the medication or
attending further reviews, they are not discharged from the service.
Time is spent with patients providing psychoeducation about the
disorder, its course and the consequences of untreated ADHD. During
these discussions it is important to acknowledge the patient’s views and
reservations, for example, stigma about a psychiatric diagnosis label,
their wish for autonomy, their view that they can manage their
symptoms without the help of medication etc. They are offered a
further appointment and are encouraged to take their time before
making a final decision. In the large majority of cases, patients decide in
favour of continuity of care.
Table 2 General recommendations for transition of care from
children’s to adult services
1. Clear transition protocols should be developed jointly by
commissioners, CAMHS/paediatric services, AMHS, primary care, and
other agencies as relevant to facilitate transition and ensure that
standards of care are maintained during the transition period.
2. These protocols should specify timeframes, lines of responsibility, who
should be involved, how the young person should be prepared, and
what should happen if AMHS are not able to accept the referral.
3. Protocols should allow for flexibility in the age of transition so as to
accommodate developmental needs and stages, but there should be
explicit referral criteria and service provision. Ideally, transition should
occur at a time of clinical stability. Patients should not have to relapse
or have worsening mental health in order to continue to be able to
access services.
4. Transition protocols should be available to all clinical teams and
should include psychoeducational material that provides high-quality,
comprehensive, impartial and appropriately written information for
both young people and their parents and carers. There is a need for
more age-appropriate psychoeducational material for patients at the
transition stage. This material should include information about ways
that young people can manage their own symptoms and problems,
and access advice and support. Information should also be developed
in a media format that is readily accessed by young people, e.g. use
of phone applications and internet sites.
5. The needs and wishes of parents/carers should be respected and
their ongoing involvement with the young person negotiated. Some
parallel services that can provide information and support for parents/
carers during the transition period may be required.
6. Efforts should be made to inform and educate allied professionals
who may come into contact with young people with ADHD for the
first time during the transition period, e.g. forensic medical examiners
and those working in the probation services and in correctional units
and prisons.
7. Healthcare jurisdictions should be encouraged to use similar care
pathways and outcome measures across different patient age groups.
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services for young people with ADHD, and prevent
drop out from services. The earlier recommendations
of Young et al. [33] were used as a starting point and
framework for discussion. When using these guide-
lines and recommendations, local situations will need
to be considered when designing transition services as
there is a considerable variation in service design and
delivery between regions. Consensus was reached for
general recommendations (Table 2) and specific rec-
ommendations (Table 3).
Future research
In the course of the workshop it became clear that
little is known about the outcomes of individuals with
ADHD who fall through care gaps, patients who re-
main under the care of Primary Care services
throughout transition into adulthood, interventions
that might improve the process, and patient and carer
experiences. Thus recommendations were also made
for future research into areas relevant to the transi-
tion of patients with ADHD from child to adult ser-
vices, including:
1. The reasons why patients stop taking medication
during the transition period.
2. The reasons why patients lose contact with their
ADHD healthcare system during the transition
period, including why adolescents chose to
discontinue treatment and how to address issues of
decreased efficacy of medication over time.
3. Pharmacological strategies to identify patients,
before their transition to adult services, who are at
risk of developing comorbid psychiatric difficulties,
with a view to preventing the development of these
comorbid problems.
4. The effectiveness of non-pharmacological interven-
tions in this age group.
Table 3 Specific recommendations for transition of care from
children’s to adult services
1. A planned transfer to an adult service should be made if the young
person continues to have significant symptoms of ADHD or other co-
existing conditions that require treatment
2. Transition should be planned well in advance by both referring and
receiving services. Timings of transition may vary but should ordinarily
be completed by the age of 18 years. Transition between teams
should be a gradual process and should be thought of as a ‘process’
and not a ‘single event’.
3. Patients should be involved in discussion about transition and
informed of the outcome of any transition assessment. The transition
process should proceed according to need in terms of future medical
care (e.g. involvement of general practitioner [GP] services, specialist
adult ADHD teams, adult learning disability services, adult physical
health teams). Importantly, the GP should be involved throughout the
process.
4. Discussion, and where necessary, joint meetings between child and
adult services must ensure that the needs of the young person will
be appropriately met. It is important to consider the presence of
comorbid and/or related problems, which may involve further
discussion and collaboration with educational, or occupational and
social agencies.
5. CAMHS practitioners and paediatricians should foster engagement with
AMHS through open discussion and psychoeducation about ADHD, the
benefit of evidenced-based psychological and pharmacological treat-
ment where appropriate, and the risks of disengagement. It is important
to address concerns about stigma associated with referral to AMHS.
6. For young people aged 16 years or over in CAMHS, a CPA should be
used to aid transfer. CPAs are not available in paediatric practice, and so
a planned assessment of need with the young person and their
parents/carers and a clearly documented plan of action is
recommended.
7. Parents/carers need to be prepared and facilitated to aid their child’s
gradual move towards independence and autonomy (with respect to
the management and treatment of their ADHD). The referring and
receiving healthcare teams should be mindful of possible parental
ADHD and when this is present (or suspected) provide appropriate
support.
8. Shared care arrangements between primary and secondary care
services for the prescription and monitoring of ADHD medications
should be continued into adulthood.
9. Direct psychological treatment should be considered (individual and/or
group Cognitive Behavioural Therapy) to support young people during
key transitional stages. This should have a skills development focus and
target a range of areas including ADHD symptoms, social skills,
interpersonal relationship problems (with peers and family), problem
solving, self-control, dealing with and expressing feelings. Active learning
strategies should be used.
10. Specific protocols need to be developed for young people who are
not accepted by AMHS criteria, but whom the referring service
strongly believe need ongoing support. Care needs to be taken that
these patients are not left without the support they need during this
very important transition period.
11. Separate care pathways should be developed for young people who
drop out of CAMHS or paediatric services when they are under
18 years of age, and who later re-present in the healthcare system as
adults.
12. Separate care pathways should be developed for patients who come
to the attention of the healthcare system on account of ADHD for
the first time as adults.
13. The referral letter from children’s services should provide a
comprehensive account of the patient, including: diagnostic summary
and formulation; treatment history; rationale and response; side effects,
Table 3 Specific recommendations for transition of care from
children’s to adult services (Continued)
compliance, abuse and diversion issues, and ongoing treatment needs;
any psychiatric and medical comorbidities, their impact on ADHD and
treatment; any other ongoing needs - social, financial, accommodation
or occupational and an updated risk assessment.
14. The adult service should acknowledge the receipt of the referral. The
patient should not be discharged by the children’s services until
they have been seen by the adult services and their care has
formally been taken over by the adult services. This provides a safety
net and reduces the likelihood of patients dropping out of the
services during the transition period.
15. Following acceptance of the referral, the adult service should allocate a
key worker/lead clinician who will coordinate the care needed.
16. When dealing with patients who are anxious about the transfer of
care to adult services or those with complex needs, it may be
necessary for children’s services to joint work with adult services for
a few months to facilitate the transfer of care.
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5. Females with ADHD are underrepresented in the
research literature, and their position through the
transition process demands more attention.
Conclusions
Transition is a process, not an event, and normally oc-
curs by the age of 18. However, flexibility is required to
accommodate individual needs. Unfortunately, transition
is often poorly planned, executed and experienced. Ad-
herence to clear recommendations is necessary to ensure
effective transition and prevent drop-out from services.
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